Expanding Site Capacity for Cell & Gene Therapy Success

Connect with Our Experts

 

As the cell and gene therapy (CGT) pipeline continues to grow, developers face a persistent challenge: limited access to CGT-experienced sites. Traditional centers are oversubscribed, while qualified but underutilized or naïve sites remain untapped.

To advance CGT programs efficiently, sponsors must expand and strengthen their site networks with the right support and strategic collaboration.

 

Our experts can help you:

  • Find and prepare the right sites: Discover emerging centers with potential and build the confidence and capabilities they need to run CGT trials successfully.
  • Accelerate study start-up: Reduce delays with proactive planning, streamlined activation, and hands-on operational support.
  • Build sustainable site partnerships: Create long-term relationships and site models that foster consistency, communication, and quality over time.
  • Simplify oversight and compliance: Navigate IBC and regulatory requirements with practical guidance that helps you stay compliant while keeping timelines on track.

Connect with our experts to explore how we can help expand your CGT site capacity and strengthen your development infrastructure—driving your programs forward with confidence.

 

Meet our Experts

Jess-Merryfield kenneth_headshot-unsmushed greg-unsmushed
Jessica Merryfield – Vice President, Project Delivery, Cell & Gene Therapy  Kenneth Ndugga-Kabuye, M.D., FACMG — Vice President, Cell & Gene Therapy Greg Meyer, RAC, CQA — Vice President, Regulatory Affairs

Ready to get started?